ESCMID Global: Maternal RSV vaccination reduces risk of infant hospitalization by more than 80%, according to major UKHSA study

/PRNewswire/ — Presented today at ESCMID Global 2026, the largest real-world study of its kind shows that maternal respiratory syncytial virus (RSV) vaccination reduces the…